Page last updated: 2024-08-22

galactosamine and Multiple Organ Failure

galactosamine has been researched along with Multiple Organ Failure in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Bhadauria, M; Nirala, SK; Rakshit, S1
Bohlinger, I; Gantner, F; Germann, PG; Leist, M; Tiegs, G; Wendel, A1
Fukui, H; Kikuchi, E; Matsumoto, M; Matsumura, M; Tsujii, T; Tsujita, S; Uemura, M1

Other Studies

3 other study(ies) available for galactosamine and Multiple Organ Failure

ArticleYear
Gallic Acid Protects from Acute Multiorgan Injury Induced by Lipopolysaccharide and D-galactosamine.
    Current pharmaceutical biotechnology, 2020, Volume: 21, Issue:14

    Topics: Acute Disease; Animals; Antioxidants; Brain; Dose-Response Relationship, Drug; Galactosamine; Gallic Acid; Glutathione; Humans; Kidney; Lipid Peroxidation; Lipopolysaccharides; Liver; Male; Multiple Organ Failure; Oxidative Stress; Protective Agents; Rats, Wistar; Superoxide Dismutase

2020
Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models.
    The American journal of pathology, 1995, Volume: 146, Issue:5

    Topics: Animals; Apoptosis; Dactinomycin; DNA; Galactosamine; Lipopolysaccharides; Liver; Liver Failure; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Multiple Organ Failure; Proteins; RNA; Shock, Septic; Tumor Necrosis Factor-alpha

1995
Effect of prostaglandin E1 on experimental acute hepatic failure in rabbits: prostaglandin E1 prevents the development of multiple-organ failure.
    Journal of hepatology, 1994, Volume: 20, Issue:4

    Topics: Alprostadil; Animals; Galactosamine; Hepatic Encephalopathy; Male; Multiple Organ Failure; Rabbits; Regional Blood Flow

1994